Epidemiology of Visceral Leishmaniasis in Georgia

• Giorgi Babuadze ,

  * E-mail: gbabuadze@ncdc.ge (GB); Harry.De-Koning@glasgow.ac.uk (HPdK)

  Affiliations National Center for Disease Control and Public Health of Georgia, Tbilisi, Georgia, Ilia State University, Tbilisi, Georgia

  ⨯
• Jorge Alvar,

  Current address: Drugs for Neglected Diseases Initiative, Geneva, Switzerland.

  Affiliation WHO/NTD/Leishmaniasis Program, Geneva, Switzerland

  ⨯
• Daniel Argaw,

  Affiliation World Health Organization/NTD, Geneva, Switzerland

  ⨯
• Harry P. de Koning ,

  * E-mail: gbabuadze@ncdc.ge (GB); Harry.De-Koning@glasgow.ac.uk (HPdK)

  Affiliation Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Merab Iosava,

  Affiliation National Center for Disease Control and Public Health of Georgia, Tbilisi, Georgia

  ⨯
• Merab Kekelidze,

  Affiliation National Center for Disease Control and Public Health of Georgia, Tbilisi, Georgia

  ⨯
• Nikoloz Tsertsvadze,

  Affiliation National Center for Disease Control and Public Health of Georgia, Tbilisi, Georgia

  ⨯
• David Tsereteli,

  Affiliation National Center for Disease Control and Public Health of Georgia, Tbilisi, Georgia

  ⨯
• Giorgi Chakhunashvili,

  Affiliation National Center for Disease Control and Public Health of Georgia, Tbilisi, Georgia

  ⨯
• Tamar Mamatsashvili,

  Affiliation National Center for Disease Control and Public Health of Georgia, Tbilisi, Georgia

  ⨯
• Nino Beria,

  Affiliation National Center for Disease Control and Public Health of Georgia, Tbilisi, Georgia

  ⨯
• Irine Kalandadze,

  Affiliation National Center for Disease Control and Public Health of Georgia, Tbilisi, Georgia

  ⨯
• Mikhail Ejov,

  Affiliation World Health Organization, Regional Office for Europe, Copenhagen, Denmark

  ⨯
• Paata Imnadze

  Affiliation National Center for Disease Control and Public Health of Georgia, Tbilisi, Georgia

  ⨯